Attached files
file | filename |
---|---|
10-Q/A - MEDISAFE 1 TECHNOLOGIES CORP | v191394_10qa.htm |
EX-32.1 - MEDISAFE 1 TECHNOLOGIES CORP | v191394_ex32-1.htm |
EX-32.2 - MEDISAFE 1 TECHNOLOGIES CORP | v191394_ex32-2.htm |
EX-31.1 - MEDISAFE 1 TECHNOLOGIES CORP | v191394_ex31-1.htm |
EXHIBIT
31.2
CERTIFICATION
OF
PRINCIPAL
FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO
SECTION
302(a) OF THE SARBANES-OXLEY ACT OF 2002
I,
Yisrael Gottlieb (Principal Financial and Accounting Officer) of Medisafe 1
Technologies Corp . (the “Company”), certify that:
1. I
have reviewed this quarterly report on Form 10-Q of the Company for the quarter
ended March 31 2010
2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
3. Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the Company as of, and for,
the periods presented in this report;
4. I
am responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rule
13a-15(f) and 15d-15(f) for the Company and have:
|
a.
|
Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information
relating to the Company, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the
period in which this report is being
prepared;
|
|
b.
|
Designed such internal control
over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance
with generally accepted accounting
principles;
|
|
c.
|
Evaluated the effectiveness of
the Company's disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based
on such evaluation; and
|
|
d.
|
Disclosed in this report any
change in the Company’s internal control over financial reporting that
occurred during the Company’s most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the
Company’s internal control over financial
reporting.
|
5. I
have disclosed, based on my most recent evaluation of internal control over
financial reporting, to the Company’s auditors and the audit committee of the
Company’s board of directors (or persons performing the equivalent
functions):
|
a.
|
All significant deficiencies and
material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the
Company’s ability to record, process, summarize and report financial
information; and
|
|
b.
|
Any fraud, whether or not
material, that involves management or other employees who have a
significant role in the Company’s internal control over financial
reporting.
|
Date:
July 26, 2010
|
By:
|
/s/ Yisrael
Elhadad
|
Name:
Yisrael Gottleb
|
||
Title: Secretary
and Director
|
||
(Principal
Internal Accounting
Officer)
|